Integrated Pharmaceuticals Income Statement

Health Care & Life Sciences » Pharmaceuticals | Integrated Pharmaceuticals Inc.

Integrated Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.

2015

Cost of Goods Sold (COGS) incl. D&A

743.00

Gross Income

743.00

SG&A Expense

6,825.00

EBIT

7,568.00

Non Operating Income/Expense

209.00

Pretax Income

7,147.00

Consolidated Net Income

7,147.00

Net Income

7,147.00

Net Income After Extraordinaries

7,147.00

Net Income Available to Common

7,147.00

EPS (Basic)

0.92

Basic Shares Outstanding

7,800.00

EPS (Diluted)

0.92

Diluted Shares Outstanding

7,800.00

EBITDA

6,825.00

Non-Operating Interest Income

630.00

View Profile

Address	5727 E. Canyon Ridge North Drive Cave Creek Arizona 85331 United States
Employees	-
Website	-
Updated	07/08/2019
Integrated Pharmaceuticals, Inc. engages in the development of technologies for the production of clinically active compounds. Its activities include the improvement of active small molecules and recombinant DNA technology products. The company was founded in 1969 and is headquartered in Cave Creek, AZ.